News & Insights
Sort By
Insights 1 result
Insights
|March 5, 2024
BioPharma Quotes Tim Ehrlich in "Biotech IPOs heated up to start 2024. Will the surge last?"
BioPharma's article on the biotechnology sector's notable resurgence in IPOs quotes Gunderson Boston partner Tim Ehrlich.
Events 1 result
Events
|February 7, 2024
Webinar: “What’s Market” in University Licenses in the Life Science Industry
Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.
Client News 27 Results
Client News
|July 24, 2025
TCG Labs Soleil Announces $400M Funding Raise
Venture firm integrating capital with an in-house biotech R&D hub, TCG Labs Soleil, announces its $400 million funding raise
Client News
|June 3, 2025
Hims & Hers Announces Definitive Agreement to Acquire ZAVA
Leading health and wellness platform, Hims & Hers, announces its definitive agreement to acquire Europe-based digital health platform, ZAVA
Client News
|May 27, 2025
Cambridge-based biopharmaceutical company pioneering RNAi-based medicine, City Therapeutics, announces its $ 1 billion strategic collaboration with Biogen Inc., a company focused on pioneering innovative science to deliver new medicines
Firm News 8 Results
Firm News
|August 6, 2025
Joyce Hu Joins Gunderson Dettmer Beijing as Of Counsel
We are delighted to announce that Joyce Hu has joined our Beijing office as Of Counsel. Joyce is a valued member of our China and Life Sciences practice groups, where she focuses on representing emerging growth companies in the life sciences and technology sectors throughout their corporate lifecycles.
Firm News
|March 5, 2025
Gunderson Dettmer Welcomes Adrian Rich as a New Life Sciences Partner in Northern California
Gunderson Dettmer announces the addition of Life Sciences Partner, Adrian Rich, based in the Northern California offices
Firm News
|January 11, 2024
Gunderson Dettmer's Life Sciences Group participated across events during the 2024 JPM Healthcare Conference. The JP Morgan Healthcare Conference is the largest and most informative healthcare investment symposium, which connects global industry leaders, emerging fast-growth companies, innovative technology creators, and investment community members.